TearLab Corporation (TEAR)
(Delayed Data from OTC)
$0.06 USD
0.00 (0.00%)
Updated Jul 9, 2020 09:35 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
TearLab Corporation [TEAR]
Reports for Purchase
Showing records 81 - 100 ( 165 total )
Company: TearLab Corporation
Industry: Medical - Instruments
3Q Miss Inline with Our Recent Downward Revisions but Below Consensus
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
AAO Takeaways - Lowering Projections to Reflect More Conservative Outlook
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
American Academy of Ophthalmology conference takeaways, reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
3Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Analyst Day Details Commercial Strategies and Next-Gen Platform; Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
"Buy the dip" - thoughts from the TearLab Analyst Day, reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Encouraging 2Q Utilization Trends; Lowered Guidance as Expected
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
2Q Preview: Looking for More Visibility on 2014 Outlook
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
2Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation UpdateThis report contains brief updates on the following: ALGN, BABY, ETRM, EXAS, ICUI, LMAT, MASI, NSPH, TEAR, TRIB, UPI, VOLC. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
Notes from the road, reiterate STRONG BUY, $10.50 price target
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
Q1 results miss, guidance maintained, reiterate STRONG BUY, price target to $10.50
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.